Chronic myocardial hibernation in humans

Circulation

Volumn 95, Issue 7, 1997, Pages 1961-1971

  Vanoverschelde, Jean Louis J ^a,d   Wijns, William ^b   Borgers, Marcel ^c   Heyndrickx, Guy ^b   Depré, Christophe ^a   Flameng, Willem ^e   Melin, Jacques A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CARDIOVASCULAR CENTER   (Belgium)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e NONE

Author keywords

blood flow; metabolism; myocardium; stunning, myocardial; tomography

Indexed keywords

ADRENALIN; DOBUTAMINE; FIBRINOLYTIC AGENT;

CELL DAMAGE; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; HEART CONTRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; INOTROPISM; MORPHOLOGY; MYOCARDIAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STUNNED HEART MUSCLE;

EID: 0030893394     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.7.1961     Document Type: Review

References (106)

1. Tennant R, Wiggers CJ. The effects of coronary occlusion on myocardial contraction. Am J Physiol. 1935;112:351-361.
2. Braunwald E, Rutherford J. Reversible ischemic left ventricular dysfunction: evidence for 'hibernating myocardium.' J Am Coll Cardiol. 1986;8:1467-1470.
3. Kloner RA, Przyklenk K, Patal B. Altered myocardial states: the stunned and hibernating myocardium. Am J Med. 1989;86(suppl 1A):14-22.
4. Rahimtoola S. The hibernating myocardium. Am Heart J. 1989;117:211-221.
5. Rahimtoola S. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for stable angina. Circulation. 1985;72(suppl V):V-123-V-135.
6. Diamond GA, Forrester JS, deLuz PL, Wyatt HL, Swan HJC. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J. 1978;95:204-209.
7. Topol EJ, Weiss JL, Guzman PA, Dorsey-Lima S, Blank T, Humphrey L, Baumgartner W, Flaherty J, Reitz B. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: detection by intraoperative transesophageal echocardiography. J Am Coll Cardiol. 1984;4:1123-1134.
8. Ross J Jr. Myocardial perfusion-contraction matching. Circulation. 1991;83:1076-1083.
9. Gallagher KP, Kumada T, Koziol JA, McKown MD, Kemper WS, Ross J. Significance of regional wall thickening abnormalities relative to transmural myocardial perfusion in anesthetized dogs. Circulation. 1980;62:1266-1274.
10. Gallagher KP, Matsuzaki M, Koziol JA, Kemper WS, Ross J. Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. Circ Res. 1983;52:716-729.
11. Vatner SF. Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res. 1980;47:201-207.
12. Eckenhoff JE, Hafkenschiel C, Landmesser M, Harmel MH. Cardiac oxygen metabolism and control of the coronary circulation. Am J Physiol. 1947;149:634-640.
13. Heyndrickx GR, Millard RW, Mc Ritchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary occlusions in conscious dogs. J Clin Invest. 1975;56:978-985.
14. Jennings RB, Sommers HM, Smyth GA, Flack HH, Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol. 1960;70:68-78.
15. Matsuzaki M, Gallagher KP, White F, Ross J Jr. Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion. Circulation. 1983;68:170-182.
16. Fedele F, Gewirtz H, Capone R, Sharaf B, Most A. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation. 1988;78:729-735.
17. Pantely G, Malone S, Rhen W, Anselone C, Arai A, Brislow J, Brislow J. Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res. 1990;67:1481-1493.
18. Arai A, Pantely G, Anselone C, Brislow J, Brislow JD. Active down regulation of myocardial energy requirements during moderate ischemia in swine. Circ Res. 1991;69:1458-1469.
19. Schulz R, Guth BD, Pieper K, Martin C, Heusch G. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: a model of short-term hibernation. Circ Res. 1992;70:1282-1295.
20. Schulz R, Rose J, Martin C, Brodde O, Heusch G. Development of short-term myocardial hibernation: its limitation by the severity of ischemia and inotropic stimulation. Circulation. 1993;88: 684-695.
21. Canty JM Jr, Klocke F. Reductions in regional myocardial function at rest in conscious dogs with chronically reduced regional coronary artery pressure. Circ Res. 1987;61(suppl II):II-107-II-116.
22. Bolukoglu H, Liedtke J, Nellis S, Eggleston A, Subramanian R, Renstrom B. An animal model of chronic coronary stenosis resulting in hibernating myocardium. Am J Physiol. 1992;263:H20-H29.
23. Liedtke AJ, Renstrom B, Nellis SH, Hall JL, Stanley WC. Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis. J Am Coll Cardiol. 1995;26:815-825.
24. Shen YT, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: hibernation versus stunning? Circ Res. 1995;76:479-488.
25. 18F-2-deoxyglucose (FDG) deposition in pigs with collateral-dependent myocardium and chronic hibernation. Circulation. 1995;92(suppl I):I-386. Abstract.
26. Gerber B, Laycock SK, Melin JA, Flameng W, Vanoverschelde J-L. Perfusion-contraction matching, inotropic reserve and vasodilatory capacity in a canine model of dysfunctional collateral-dependent myocardium. Circulation. 1995;92(suppl I):I-314. Abstract.
27. Berger BC, Watson DD, Burwell LR, Crosby IK, Wellons HA, Teates CD, Beller GA. Redistribution of thallium at rest in patients with stable and unstable angina and the effects of coronary artery bypass graft surgery. Circulation. 1979;60:1114-1125.
28. Iskandrian AS, Hakki AH, Kane SA, Goel IP, Mundth ED, Hakki AH, Segal BL. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol. 1983;51: 1312-1316.
29. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630-1641.
30. Marwick TH, Maclntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization: a follow-up study of regional perfusion, function and metabolism. Circulation. 1992;85:1347-1353.
31. 99mTc-sestamibi. Circulation. 1994;89:2552-2561.
32. Vanoverschelde J-LJ, Wijns W, Depré C, Essamri B, Heyndrickx G, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral dependent myocardium. Circulation. 1993;87:1513-1523.
33. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography, 1: effect of object size. J Comput Assist Tomogr. 1979;3:299-308.
34. Parodi O, Schelbert HR, Schwaiger M, Hansen H, Selin C, Hoffman EJ. Cardiac emission computed tomography: underestimation of regional tracer concentration due to wall motion abnormalities. J Comput Assist Tomogr. 1984;8:1083-1092.
35. Schelbert HR, Phelps ME, Hoffman EJ, Huang SC, Selin CE, Kuhl DE. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol. 1979;43:209-218.
36. Bergmann SR, Herrero P, Markham J, Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol. 1989;14:639-652.
37. 15O]water estimates of perfusion with quantitation of regional myocardial blood flow by microspheres. Circulation. 1993;87: 512-525.
38. Marshall M, Tillish JH, Phelps ME, Huang SC, Carson R, Henze E, Schelbert HR. Identification and differentiation of resting myocardial ischemia and infarction in man with positron emission tomography, F-18-labeled fluorodeoxyglucose and N-13 ammonia. Circulation. 1983;67:766-778.
39. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps ME, Schelbert HR. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884-888.
40. Tamaki N, Kawamoto M, Takahashi N, Yonekura Y, Magata Y, Nohara R, Kambara H, Sasayama S, Hirata K, Ban T, Konishi J. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol. 1989; 64:860-865.
41. Grandin C, Wijns W, Melin JA, Bol A, Robert A, Heyndrickx GR, Michel C, Vanoverschelde J-L. Delineation of myocardial viability with positron emission tomography. J Nucl Med. 1995;36:1543-1552.
42. Gerber BL, Vanoverschelde J-L, Bol A, Michel C, Labar D, Wijns W, Melin JA. Myocardial blood flow, glucose uptake and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic myocardial hibernation. Circulation. 1996;94:651-659.
43. Sambuceti G, Parodi O, Marzullo P, Giorgetti A, Fusani L, Puccini G, Salvadori P, L'Abbate A. Regional myocardial blood flow in stable angina pectoris associated with isolated significant narrowing of either the left anterior descending or left circumflex coronary artery. Am J Cardiol. 1993;72:990-994.
44. Iida H, Rhodes C, de Silva R, Yamamoto Y, Araujo L, Maseri A, Jones T. Myocardial tissue fraction: correction for partial volume effects and measure of tissue viability. J Nucl Med. 1991;32:2169-2175.
45. Herrero P, Staudenherz A, Walsh JF, Gropler RJ, Bergmann SR. Heterogeneity of myocardial perfusion provides the physiological basis of 'perfusable tissue index.' J Nucl Med. 1995;36:320-327.
46. de Silva R, Yamomoto Y, Rhodes CG, Iida H, Nihoyannopoulos P, Davies GJ, Lammertsma AA, Jones T, Maseri A. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation. 1992;86:1738-1742.
47. Marinho NVS, Keogh BE, Costa DC, Ell PJ, Lammertsma AA, Eli PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction: new insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation. 1996;93:737-744.
48. Conversano A, Walsh JF, Geltman EM, Pérez JE, Bergmann SR, Gropler RJ. Delineation of myocardial stunning from hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J. 1996;131:440-450.
49. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-1149.
50. Kitakaze M, Marban E. Cellular mechanism of the modulation of contractile function by coronary perfusion pressure in ferret hearts. J Physiol (Lond). 1989;414:455-472.
51. Bache RJ, Schwartz JS. Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow. Circulation. 1982;65:928-935.
52. Weisfeldt ML, Shock NW. Effect of perfusion pressure on coronary flow and oxygen usage of nonworking heart. Am J Physiol. 1970; 218:H95-H101.
53. Berman M, Fischman AJ, Southern J, Carter E, Mirecki F, Strauss W, Nunn A, Gewirtz H. Myocardial adaptation during and after sustained, demand-induced ischemia. Circulation. 1996;94:755-762.
54. Mills I, Fallon JT, Wrenn D, Sasken H, Gray W, Bier J, Levine D, Berman S, Gilson M, Gewirtz H. Adaptive responses of coronary circulation and myocardium to chronic reduction in perfusion pressure and flow. Am J Physiol. 1994;266:H447-H457.
55. Flameng W, Suy R, Schwartz F, Borgers M, Piessens J, Thone F, Van Ermen H, De Geest H. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of reversible segmental asynergy post-revascularization surgery. Am Heart J. 1981;102:846-857.
56. Flameng W, Wouters L, Sergeant P, Lewi P, Borgers M, Thone F, Suy R. Multivariate analysis of angiographic histologic and electrocardiographic data in patients with coronary disease. Circulation. 1984;70:7-17.
57. Flameng W, Vanhaecke J, Van Belle H, Borgers M, De Beer L, Minten J. Relation between coronary artery stenosis and myocardial purine metabolism, histology and regional function in humans. J Am Coll Cardiol. 1987;9:1235-1242.
58. Borgers M, Thoné F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol. 1993;2:237-245.
59. Ausma J, Schaart G, Thoné F, Shivalkar B, Flameng W. Depré C, Vanoverschelde J-L, Ramaekers F, Borgers M. Chronic ischemic viable myocardium in man: aspects of dedifferentiation. Cardiovasc Pathol. 1995;4:29-37.
60. Gropler RL, Geltman EM, Sampathkumaran K, Pérez JE, Moerlein SM, Sobel BE, Bergmann SR, Siegel BA. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol. 1992;20:569-577.
61. Maki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki L-M, Ruotsalainen U, Haaparanta M, Solin O, Hartiala J, Härkönen R, Knuuti MJ. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation. 1996;93:1658-1666.
62. Gerber B, Melin JA, Bol A, Vanoverschelde J-L. Attenuated response of myocardial glucose utilization to insulin stimulation in hibernating myocardium. Circulation. 1995;92(suppl I):I-313. Abstract.
63. Depré C, Vanoverschelde J-LJ, Melin JA, Borgers M, Bol A, Ausma J, Dion R, Wijns W. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol. 1995;268:H1265-H1275.
64. Schelbert HR, Buxton D. Insights into coronary artery disease gained from metabolic imaging. Circulation. 1988;78:496-505.
65. Vanoverschelde J-L, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic injury and functional recovery after reperfusion. Am J Physiol. 1994;267:H1785-H1794.
66. McNulty PH, Luba MC. Transient ischemia induces regional myocardial glycogen synthase activation and glycogen synthesis. Am J Physiol. 1995;268:H364-H370.
67. Bolukoglu H, Goodwin GW, Guthrie PH, Carmical SG, Chen TM, Taegtmeyer H. Metabolic fate of glucose in reversible low-flow ischemia of the isolated working rat heart. Am J Physiol. 1996;270: H817-H826.
68. Brosius FC, Sun DQ, England R, Nguyen N, Schwaiger M. Altered glucose transporter mRNA levels in cardiac ischemia. Circulation. 1993;88(suppl I):I-542. Abstract.
69. Depré C, Vanoverschelde J-L, Grillenberger K, Gerber B, Borgers M, Reske S, Wijns W, Melin JA. Correlation of glucose transporter messenger RNA expression with morphological pattern and glucose uptake in chronically dysfunctional myocardium. Circulation. 1995;92(suppl I):I-651. Abstract.
70. Manasch FJ. Mitosis in developing cardiac muscle. J Cell Biol. 1968;37:191-196.
71. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
72. Hale SL, Koner RA. Experience from experimental models in the quest to protect myocardium from ischemic damage: update on preconditioning strategies. Curr Opin Cardiol. 1994;9:411-416.
73. Brand T, Sharma HS, Fleischmann KE, Duncker DJ, McFalls EO, Verdouw PD, Schaper W. Proto-oncogenes in porcine myocardium subjected to ischemia and reperfusion. Circ Res. 1992;71:1351-1360.
74. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circ Res. 1993; 88:1264-1272.
75. Reiss K, Meggs LG, Li P, Olivetti G, Capasso JM, Anversa P. Upregulation of IGF-1, IGF-1 receptor and late growth related genes in ventricular myocytes acutely after myocardial infarction in rats. J Cell Physiol. 1994;158:160-168.
76. Kluge A, Zimmermann R, Munkel B, Verdouw PD, Schaper J, Schaper W. Insulin-like growth factor II is an experimental stress inducible gene in a porcine model of brief coronary occlusions. Cardiovasc Res. 1995;29:708-716.
77. Borgers M, Ausma J, Wijffels M, Allessie M. Atrial fibrillation in the goat: a model for chronic hibernating myocardium. Circulation. 1994;90(pt 2):I-467. Abstract.
78. Guiraudon CM, Ernst NM, Guiraudon GM, Yee R, Klein GJ. The pathology of drug resistant lone atrial fibrillation in eleven surgically treated patients. In: Kingma JH, van Hemel NM, Lie KI, eds. Atrial Fibrillation: A Treatable Disease? Dordrecht, Netherlands: Kluwer Academic Publishers; 1992:41-58.
79. Lazar HL, Plehn JF, Schick EM, Dobnik D, Shemin RJ. Effects of coronary revascularization on regional wall motion: an intraoperative two-dimensional echocardiographic study. J Thorac Cardiovasc Surg. 1989;98:498-505.
80. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with coronary artery disease. J Am Coll Cardiol. 1994;23:617-626.
81. Nienaber CA, Brunken RC, Sherman CT, Yeatman LA, Gambhir SS, Krivokapitch J, Demer LL, Ratib O, Child JS, Phelps ME, Schelbert HR. Metabolic and functional recovery of ischemic myocardium after coronary angioplasty. J Am Coll Cardiol. 1991; 18:966-978.
82. Mintz LY, Ingels HB, Daughters GI, Stinson EB, Alderman EL. Sequential studies of left ventricular function and wall motion after coronary bypass surgery. Am J Cardiol. 1980;45:210-216.
83. Vanoverschelde J-L, Melin JA, Depré C, Borgers M, Dion R, Wijns W. Time-course of functional recovery of hibernating myocardium after coronary revascularization. Circulation. 1994;90(pt 2):I-378. Abstract.
84. Shivalkar B, Maes A, Borgers M, Ausma J, Scheys I, Nuyts J, Mortelmans L, Flameng W. Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation. 1996;94:308-315.
85. Elsasser A, Muller KD, Strasser R, Vogt AM, Rau M, Klovekorn WP, Schaper J. 'Hibernating myocardium': degeneration caused by apoptosis. Circulation. 1995;92(suppl I):I-186. Abstract.
86. Becker LC, Levine JH, DiPaula AF, Guarnieri T, Aversano T. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postextrasystolic potentiation. J Am Coll Cardiol. 1986,7:580-589.
87. Ellis SG, Wynne J, Braunwald E, Henschke CI, Sandor T, Kloner RA. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J. 1984;107:13-19.
88. Chen C, Li L, Chen LL, Prada JV, Chen MH, Fallon JT, Weyman AE, Waters D, Gillam L. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation. 1995;92:756-766.
89. Sklenar J, Ismail S, Villanueva S, Goodman C, Glasheen WP, Kaul S. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: an experimental evaluation. Circulation. 1994;90:1502-1512.
90. Mertes H, Segar DS, Johnson M, Ryan T, Sawada SG, Feigenbaum H. Assessment of hibernating myocardium by dobutamine stimulation in a canine model. J Am Coll Cardiol. 1995;26:1348-1355.
91. Dyke SH, Cohn PF, Gorlin R, Sonnenblick EH. Detection of residual function in coronary artery disease using post-extrasystolic potentiation. Circulation. 1974;50:694-699.
92. Horn HR, Teichholz LE, Cohen PF, Herman MV, Gorlin R. Augmentation of left ventricular contraction patency in coronary artery disease by an inotropic catecholamine: the epinephrine ventriculogram. Circulation. 1974;49:1063-1071.
93. Popio KA, Gorlin R, Bechtel D, Levine JA. Post-extrasystolic potentiation as a predictor of potential myocardial viability: preoperative analyses compared with studies after coronary bypass surgery. Am J Cardiol. 1977;39:944-953.
94. Helfant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS. Nitroglycerin to unmask reversible asynergy: correlation with post-coronary bypass ventriculography. Circulation. 1974;50:108-113.
95. Nesto RW, Cohn LH, Collins JJ, Wynne J, Holman L, Cohn PF. Inotropic contractile reserve: a useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol. 1982;50:39-44.
96. Vanoverschelde J-L, Gerber BL, Pasquet A, Melin JA. Nuclear and echocardiographic imaging for prediction of reversible left ventricular ischemic dysfunction after coronary revascularization: current status and future directions. J Cardiovasc Pharmacol. 1996;28(suppl 1):S27-S36.
97. Piérard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol. 1990;15:1021-1023.
98. Cigarroa CG, deFilippi CR, Brickner E, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation. 1993;88:430-436.
99. Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betocchi S, Squame F, Vezzuto P, Soricelli A, Indolfi C, Salvatore M, Chiariello M. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation. 1995;91:2556-2565.
100. Vanoverschelde J-L, Gerber BL, D'Hondt A-M, De Kock M, Dion R, Wijns W, Melin JA. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation. 1995;92(suppl II):II-37-II-44.
101. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663-670.
102. 201Tl single photon emission computed tomography. Circulation. 1995;91:2748-2752.
103. Vanoverschelde J-L, D'Hondt A-M, Marwick T, Gerber BL, Wijns W, Melin JA. Head to head comparison of exercise-redistribution-reinjection thallium SPECT and low-dose dobutamine echocardiography for prediction of the reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol. 1996;28:432-442.
104. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, MacIntyre WJ, Thomas JD. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation. 1994;90:2687-2694.
105. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H, Hawkins R, Schelbert HR, Phelps ME, Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73:527-533.
106. Pasquet A, Gerber B, D'Hondt A-M, De Kock M, Melin JA, Vanoverschelde J-L. Value of dobutamine echocardiography and FDG-PET in evaluating prognosis in patients with chronic left ventricular ischemic dysfunction. Circulation. 1995;92(suppl I):I-268. Abstract.